18F-FDG PET/CT imaging versus dynamic contrast-enhanced CT for staging and prognosis of inflammatory breast cancer

@article{Champion201318FFDGPI,
  title={18F-FDG PET/CT imaging versus dynamic contrast-enhanced CT for staging and prognosis of inflammatory breast cancer},
  author={Laurence Champion and Florence Lerebours and Pierre Cherel and V{\'e}ronique Edeline and Anne-Laure Giraudet and Myriam Brugi{\`e}re Wartski and Dominique Bellet and J L Alb{\'e}rini},
  journal={European Journal of Nuclear Medicine and Molecular Imaging},
  year={2013},
  volume={40},
  pages={1206-1213}
}
PurposeInflammatory breast cancer (IBC) is the most aggressive type of breast cancer with a poor prognosis. Locoregional staging is based on dynamic contrast-enhanced (DCE) CT or MRI. The aim of this study was to compare the performances of FDG PET/CT and DCE CT in locoregional staging of IBC and to assess their respective prognostic values.MethodsThe study group comprised 50 women (median age: 51 ± 11 years) followed in our institution for IBC who underwent FDG PET/CT and DCE CT scans (median… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-7 OF 7 CITATIONS

18F-FDG PET/CT to Predict Response to Neoadjuvant Chemotherapy and Prognosis in Inflammatory Breast Cancer.

  • Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • 2015
VIEW 2 EXCERPTS
CITES BACKGROUND & METHODS

References

Publications referenced by this paper.
SHOWING 1-10 OF 37 REFERENCES

Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2002
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Imaging in inflammatory breast carcinoma.

  • Breast disease
  • 2005
VIEW 11 EXCERPTS
HIGHLY INFLUENTIAL

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2011
VIEW 1 EXCERPT